Document is current
Any future updates will be listed below
-
Authors
Cui, Haotian https://orcid.org/0000-0001-8119-9485
Tejada-Lapuerta, Alejandro
Brbić, Maria https://orcid.org/0000-0002-1120-1778
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Cristea, Simona
Goodarzi, Hani https://orcid.org/0000-0002-9648-8949
Lotfollahi, Mohammad
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
- License Information
-
More Information
Article History
Received: 17 October 2023
Accepted: 29 January 2025
First Online: 16 April 2025
Competing interests
: F.J.T. consults for Immunai, CytoReason, Cellarity, BioTuring and Genbio.AI, and has an ownership interest in Dermagnostix GmbH and Cellarity. B.W. serves as a scientific advisor to Shift Bioscience, Deep Genomics and Vevo Therapeutics, and acts as a consultant for Arsenal Bioscience. H.G. has an ownership interest in Vevo Therapeutics, and is an advisor to Verge Genomics and Deep Forest Biosciences. J.S.-R. reports funding from GSK, Pfizer and Sanofi, and fees and/or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, Grunenthal, Moderna and Tempus. M.L. owns interests in Relation Therapeutics and AIVIVO, and is a scientific cofounder and part-time employee at AIVIVO. The other authors declare no competing interests.
